Montelukast Prescribing at PARKVIEW SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
562
Total Quantity
15.3K
NHS Cost
£737
vs National Avg
-17.9%
PARKVIEW SURGERY prescribed 562 items of Montelukast over the last 12 months at a cost of £737 to the NHS. This is 17.9% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
53
Jun 2026
41
Jun 2026
47
Jun 2026
43
Jun 2026
43
Jun 2026
52
Jun 2026
44
Jun 2026
45
Jun 2026
50
Jun 2026
46
Jun 2026
50
Jun 2026
48
Prescribing Details
| Total Items | 562 |
|---|---|
| Total Quantity | 15,260 |
| Total NHS Cost | £737 |
| Presentations | 3 different forms |
| vs National Average | -17.9% |
Montelukast Prescribing Comparison
| This practice | 562 items |
|---|---|
| National average per practice | 685 items |
| Difference | -17.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.